Sacral neuromodulation shows efficacy in OAB patients with Parkinson’s disease


“Of those patients that did the test phase 82% of them actually went on to full implants,” says Sarah Martin, DO.

In this video, Sarah Martin, DO, discusses the background and key findings from the recent Neurourology & Urodynamics study, “Is sacral neuromodulation effective in patients with Parkinson's disease? A retrospective review,” for which she served as first author. Martin is an FPMRS fellow at Glickman Urological & Kidney Institute at Cleveland Clinic.

Related Videos
United States Capitol Building | Image Credit: © rrodrickbeiler -
Roger R. Dmochowski, MD, MMHC, FACS, answers a question during a Zoom video interview
Smita De, MD, PhD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.